Exits: Where to find liquidity, when to execute
- What is the outlook for distributions from Asia over the next 12 months?
- Which are the most viable IPO destinations for start-ups in the region?
- How can a balance be struck between meeting liquidity needs and optimising returns?
- Why have there been so few GP-led secondaries in Asia VC?
Speakers
Confirm cancellation
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports
Pang Lee routinely advises on partnership, corporate and securities law matters related to the organization and investment in private funds and strategic investments in the tech industry. Pang has worked closely with members of the Hong Kong start-up community cultivating its emerging companies ecosystem, with a particular focus in healthcare and emerging technology companies. Pang regularly advises private fund managers and institutional investors on United States and Hong Kong regulatory, corporate governance, and risk-related matters.
Markus is a Partner in the Antler Singapore office, where he shares the overall responsibility for Antler’s operations in Southeast Asia. Markus has worked with technology ventures in Southeast Asia for nearly a decade.
Prior to Antler, Markus was Corporate Development Manager at Global Fashion Group (GFG) / Zalora Group working in Singapore, Indonesia and the Philippines. He holds a Master’s degree in Banking and Finance from the University of St.Gallen, Switzerland. LinkedIn:
https://www.linkedin.com/in/mbruderer/
Amish has working in the Investing and Advisory industry since 2007. Chiratae Ventures is a leading VC firm managing assets under management (AUM) of $1.2 billion. The firm has invested in over 130 companies, achieved exits in more than 50, taken 4 companies public, funded 9 unicorns, and backed over 15 market leaders.
His experience spans Agri Tech, Consumer Tech, Enterprise Tech, Fintech, Ed Tech and Retail sectors. Experience includes M&A advisory, Fund Raising and Capital Markets.
In recognition of his contributions, Amish was named one of the leading venture capitalists in India by IndiaStartupTimes in 2024. He has also been listed by EconomicTimes among the experts hired by VCs to help in Exits published in 2024.
Beyond his role at Chiratae Ventures, he is serving with Jain International Trade Organization (JITO) to augment the Portfolio Review process and Volunteers with Tarun Mitra Mandal’s initiatives in Eye Donation and Blood Donation.
Grace Lee is a Partner and Group COO of Qiming Venture Partners. She has extensive experience in the venture capital industry covering investment, portfolio management, fund operation and fund raising. Prior to joining Qiming in 2009, Grace was the Deputy CFO and Compliance Officer of C.V. Starr Asia. Previously, Grace was an investment professional dealing with private equities and listed securities when she worked at PAI Partners and JAFCO Asia. Grace was an auditor in the early part of her career life.
Grace was named the Top 10 Most Influential CFO in the China VC/PE Industry in 2017 by China Venture, and the Top 10 China VC/PE CFO in 2022 by Frost & Sullivan and Lead Leo Technology & Innovation Network.
She holds a Bachelor of Business Administration Degree from the Chinese University of Hong Kong and a Bachelor of Laws Degree from the University of London. She is a fellow member of HKICPA and a CFA charter holder. Grace is a co-founder of Hong Kong Private Equity Finance Association, and a director of China Venture Capital Finance Organization.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since its establishment, the firm has invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.